pharma · Metastatic Breast Cancer · Advanced Ovarian Cancer · ALLR
Allarity Therapeutics
Allarity Therapeutics is a pharma organization headquartered in Tarpon Springs, USA. It trades on NYSE under ticker ALLR. Primary therapeutic focus areas include Metastatic Breast Cancer, Advanced Ovarian Cancer, Advance
Tarpon Springs, USA HQ
2012 Founded
11 Employees
Public company Type
ALLR · NYSE Ticker
Company details
- Status
- Public
- HQ
- Tarpon Springs, USA
- Founded
- 2012
- Employees
- 11
- Programs
- 7
- Drugs
- 4
- Patents
- 1
Irofulven
Phase 2 · small molecule · Metastatic Castration-Resistant Prostate Cancer Patients
Irofulven for Metastatic Castration-Resistant Prostate Cancer Patients is a Phase 2 program (small_molecule) at Allarity Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code SMR-3165
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Allarity Therapeutics
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Metastatic Castration-Resistant Prostate Cancer Patients
- Status
- completed
- Trials
- 1